Cheryl Chan
Advises on public and private mergers and acquisitions, investments and joint ventures, and governance and activism. One of The Deal’s 2023 “Top Women in Dealmaking.”
Cheryl advises U.S. and international clients on public and private mergers and acquisitions, investments, joint ventures, corporate governance, shareholder activism and other general corporate matters. She also represents private equity firms and their portfolio companies on a full range of transactions, including acquisitions and dispositions of investments, leveraged buyouts and minority investments.
The Deal recognized Cheryl as one of the “Top Women in Dealmaking” in 2021, 2022 and 2023, after profiling her as a “Rising Star” in 2020. Cheryl was named a finalist for the American Lawyer’s “Corporate Attorney of the Year” award.
Experience
Public Company and Take Private Transactions
- Emerson’s:
- $11 billion majority investment in and subsequent $7.2 billion acquisition of remaining outstanding shares of AspenTech
 - $8.2 billion acquisition of National Instruments
 
 - Gilead’s:
- $21 billion acquisition of Immunomedics
 - $4.3 billion acquisition of CymaBay Therapeutics
 
 - Qorvo’s $22 billion combination with Skyworks Solutions
 - Brookfield Business Partners’ $8.3 billion take private acquisition of CDK Global
 - Comcast’s spinoff of select cable television networks
 - Livent’s $10.6 billion merger of equals with Allkem
 - Arcadium Lithium’s $6.7 billion acquisition by Rio Tinto
 - Owens Corning’s $3.9 billion acquisition of Masonite International
 - Alcoa’s $2.2 billion acquisition of Alumina
 - SS&C Technologies’ $5.4 billion acquisition of DST Systems
 - HP’s $3.3 billion acquisition of Poly
 - Bath & Body Works’s Victoria’s Secret spinoff
 - FTS International’s $407 million acquisition by ProFrac Holdings
 
Private Equity Transactions
- Brookfield Business Partners’:
- $13.2 billion acquisition of the Power Solutions business of Johnson Controls
 - $8.3 billion acquisition of CDK Global
 - $3.4 billion acquisition of DexKo Global
 
 - Emerson’s:
- sale of control of the Climate Technologies business in a $14 billion transaction to Blackstone funds
 - sale of its Therm-O-Disc business to One Rock Capital Partners
 
 - TIAA’s sale of TIAA Bank to private equity buyers
 - Arco Platform’s take private by private equity sponsors
 - Atairos’ series of transactions involving Learfield IMG College
 
Healthcare and Life Sciences
- Gilead’s:
- $21 billion acquisition of Immunomedics
 - $4.3 billion acquisition of CymaBay Therapeutics
 - $405 million acquisition of MiroBio
 
 - Shire’s acquisition of Foresight Biotherapeutics
 
Industrials and Energy
- Emerson’s:
- sale of control of the Climate Technologies business in a $14 billion transaction
 - majority investment in and subsequent proposal to acquire Aspen Technology at a $15.3 billion enterprise valuation
 - $8.2 billion acquisition of National Instruments
 
 - Owens Corning’s $3.9 billion acquisition of Masonite International
 - Alcoa’s $2.2 billion acquisition of Alumina
 - DexKo Global’s acquisition of the TexTrail businesses
 - Livent’s:
- $10.6 billion merger of equals with Allkem
 - investment in Nemaska Lithium
 
 
News
Recognition
The Deal – “Top Women in Dealmaking,” M&A, 2021, 2022 and 2023
American Lawyer - “Corporate Attorney of the Year” finalist, 2022
IFLR1000 – M&A, United States, Rising Star Partner
The Deal – “Top Rising Stars: Class of 2021”
The Deal – “Rising Star,” 2020
Education
- cum laude
 
- summa cum laude
 - Phi Beta Kappa
 
Qualifications and admissions
- State of New York